Department of Biotechnology (DBT), Biotechnology Industry Research Assistance Council (BIRAC) are organizing Global Bio-India 2021.
It is a mega international congregation of biotechnology stakeholders, including international bodies, regulatory bodies, Central and State Ministries, SMEs, large industries, bioclusters, research institutes, investors, and the startup ecosystem.
The event has representatives from 50 plus countries with Switzerland as the key partner and Karnataka as the state partner.
Three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science and Technology, and Health and Family Welfare.
It is the largest Bio event and would showcase opportunities in Indian Biotechnology sector to the world.
Multiple products by the private sector like Tech- Ola were launched.
Tech-Ola is a single window e- marketplace app, which would bring together all public and private sector laboratories, fabrication and prototyping centres.
Indian capability in Vaccine Production was applauded by WHO delegates.
India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines.
As many as 30 vaccines are at different stages of development in India.
Vaccines already in use are Covaxin, developed indigenously by Bharat Biotech.
Covishield, developed by Oxford-AstraZeneca and being manufactured at Serum Institute of India.